Phcg 426: Cancer Chemo - Targets and Discovery
Biomolecular Sciences
This course provides a general synopsis of the discovery and development of anticancer chemotherapeutics, with particular emphasis on those that are derived from natural products. The course includes discussions of the critical molecular and/or cellular events underlying the etiology and progression of cancer, anticancer target selection and validation, bioassay methods, screening libraries of compounds and/or extracts, bioassay-guided isolation and structure elucidation, and biological characterization/evaluation of active leads. Examples from four focus areas will be studied and discussed: cytotoxic agents, targeted therapies, tumor metabolism, and antimetastasis drug discovery.
2 Credits
Prerequisites
- Phcl 341: Human Pathophysiology I $target.descriptions.MinimumGrade$
- Phcl 342: Human Pathophysiology II $target.descriptions.MinimumGrade$
- Pre-requisite: Pharmacy PY2
Instruction Type(s)
- Lecture: Lecture for Phcg 426
Subject Areas
The policies and regulations contained in this online University of Mississippi Catalog are in effect for the current or selected semester. The catalog is not a contract, but rather a guide for the convenience of students. The University of Mississippi reserves the right to 1) change or withdraw courses; 2) change the fees, rules, and schedules for admission, registration, instruction, and graduation; and 3) change other regulations affecting the student body at any time. Implicit in each student’s enrollment with the university is an agreement to comply with university rules and regulations, which the university may modify to exercise properly its educational responsibility.